The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function - PubMed (original) (raw)

. 2006 Sep-Oct;89(1-2):121-8.

doi: 10.1016/j.ymgme.2006.04.005. Epub 2006 Jun 13.

Affiliations

• PMID: 16777452
• DOI: 10.1016/j.ymgme.2006.04.005

The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function

U Lichter-Konecki et al. Mol Genet Metab. 2006 Sep-Oct.

Abstract

Lowe syndrome is a rare X-linked disease characterized by congenital cataracts, defects in renal tubule cell function, and mental retardation. Mutations in the OCRL1 gene, which encodes ocrl1, a phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P(2)) 5-phosphatase, are the cause of Lowe syndrome. PtdIns(4,5)P(2), a substrate of ocrl1, is an important signaling molecule within the cell. OCRL1 is ubiquitously expressed and co-localizes with the trans-Golgi network (TGN) and endosomal proteins. The ocrl1 protein contains two recognizable domains, one a conserved Ptd(4,5)P(2) 5-phosphatase domain and the other with homology to Rho GTPase activating proteins (RhoGAPs). The objective of our study was to further characterize the ocrl1 RhoGAP-homology domain by analyzing the effect of two missense mutations in this domain, I751N and A780P, which were previously reported in Lowe syndrome patients. Both mutant proteins were expressed at levels similar to wild-type but their enzyme activity was reduced by 85-90%, indicating that the RhoGAP-homology domain is important for the enzymatic function of ocrl1. Study of a C-terminal region of wild-type ocrl1 containing this domain detected no GAP activity, eliminating the possibility of an effect by mutations in this domain on GTPase activation. Because members of the Arf family of small G-proteins are directly involved in (Ptd(4,5)P(2)) signaling and localize to the TGN like ocrl1, we analyzed by immunoprecipitation the interaction of ocrl1 with Arf1 and Arf6 via its RhoGAP-homology domain. Wild-type ocrl1, but not the I751N mutant protein, co-immunoprecipitated with these two Arf proteins. These results indicate that wild-type ocrl1 and Arf proteins can interact and that this interaction is disrupted by the mutation. It remains unknown whether a disrupted interaction between Arf and ocrl1 plays a role in the Lowe syndrome phenotype.

PubMed Disclaimer

Similar articles

• Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network.
  Faucherre A, Desbois P, Satre V, Lunardi J, Dorseuil O, Gacon G. Faucherre A, et al. Hum Mol Genet. 2003 Oct 1;12(19):2449-56. doi: 10.1093/hmg/ddg250. Epub 2003 Jul 29. Hum Mol Genet. 2003. PMID: 12915445
• A novel OCRL1 mutation in a patient with the mild phenotype of Lowe syndrome.
  Sugimoto K, Nishi H, Miyazawa T, Fujita S, Okada M, Takemura T. Sugimoto K, et al. Tohoku J Exp Med. 2014 Mar;232(3):163-6. doi: 10.1620/tjem.232.163. Tohoku J Exp Med. 2014. PMID: 24614960
• Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.
  Lin T, Orrison BM, Leahey AM, Suchy SF, Bernard DJ, Lewis RA, Nussbaum RL. Lin T, et al. Am J Hum Genet. 1997 Jun;60(6):1384-8. doi: 10.1086/515471. Am J Hum Genet. 1997. PMID: 9199559 Free PMC article.
• Structure and function of the Lowe syndrome protein OCRL1.
  Lowe M. Lowe M. Traffic. 2005 Sep;6(9):711-9. doi: 10.1111/j.1600-0854.2005.00311.x. Traffic. 2005. PMID: 16101675 Review.
• Crystal structure of the Rab binding domain of OCRL1 in complex with Rab8 and functional implications of the OCRL1/Rab8 module for Lowe syndrome.
  Hagemann N, Hou X, Goody RS, Itzen A, Erdmann KS. Hagemann N, et al. Small GTPases. 2012 Apr-Jun;3(2):107-10. doi: 10.4161/sgtp.19380. Small GTPases. 2012. PMID: 22790198 Review.

Cited by

• Participation of OCRL1, and APPL1, in the expression, proteolysis, phosphorylation and endosomal trafficking of megalin: Implications for Lowe Syndrome.
  Sandoval L, Fuentealba LM, Marzolo MP. Sandoval L, et al. Front Cell Dev Biol. 2022 Oct 20;10:911664. doi: 10.3389/fcell.2022.911664. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36340038 Free PMC article.
• Phosphoinositides and the Fate of Legionella in Phagocytes.
  Swart AL, Hilbi H. Swart AL, et al. Front Immunol. 2020 Jan 30;11:25. doi: 10.3389/fimmu.2020.00025. eCollection 2020. Front Immunol. 2020. PMID: 32117224 Free PMC article. Review.
• Function and dysfunction of the PI system in membrane trafficking.
  Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA. Vicinanza M, et al. EMBO J. 2008 Oct 8;27(19):2457-70. doi: 10.1038/emboj.2008.169. Epub 2008 Sep 11. EMBO J. 2008. PMID: 18784754 Free PMC article. Review.
• A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells.
  Nández R, Balkin DM, Messa M, Liang L, Paradise S, Czapla H, Hein MY, Duncan JS, Mann M, De Camilli P. Nández R, et al. Elife. 2014 Aug 8;3:e02975. doi: 10.7554/eLife.02975. Elife. 2014. PMID: 25107275 Free PMC article.
• OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses.
  Fuentealba LM, Pizarro H, Marzolo MP. Fuentealba LM, et al. Biomolecules. 2024 Jul 5;14(7):799. doi: 10.3390/biom14070799. Biomolecules. 2024. PMID: 39062513 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Miscellaneous

  • NCI CPTAC Assay Portal